Clinical Trial Update: Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR Function [NA]

View source ↗

Summary

A clinical trial from Emory University evaluating a novel point-of-care sweat chloride device to monitor CFTR function in cystic fibrosis; the study is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Emory University | Conditions: Cystic Fibrosis | NA | Status: NOT_YET_RECRUITING